Skip to main content
SpringerLink
Log in

Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine

  • Unknown
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Simpson CR, et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland Nature Medicine : 9 Jun 2021. Available from: URL: https://doi.org/10.1038/s41591-021-01408-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine. Reactions Weekly 1862, 11 (2021). https://doi.org/10.1007/s40278-021-98129-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-98129-x

Search

Navigation